Ensign Peak Advisors’s Repare Therapeutics RPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-344,328
| Closed | -$1.62M | – | 1733 |
|
|
2024
Q1 | $1.62M | Hold |
344,328
| – | – | ﹤0.01% | 1016 |
|
|
2023
Q4 | $2.51M | Hold |
344,328
| – | – | 0.01% | 824 |
|
|
2023
Q3 | $4.16M | Buy |
344,328
+73,425
| +27% | +$887K | 0.01% | 622 |
|
|
2023
Q2 | $2.87M | Buy |
270,903
+186,300
| +220% | +$1.97M | 0.01% | 753 |
|
|
2023
Q1 | $832K | Hold |
84,603
| – | – | ﹤0.01% | 1397 |
|
|
2022
Q4 | $1.24M | Sell |
84,603
-6,200
| -7% | -$91.2K | ﹤0.01% | 1006 |
|
|
2022
Q3 | $1.1M | Buy |
90,803
+5,480
| +6% | +$66.4K | ﹤0.01% | 1016 |
|
|
2022
Q2 | $1.19M | Sell |
85,323
-27,971
| -25% | -$391K | ﹤0.01% | 1038 |
|
|
2022
Q1 | $1.61M | Buy |
113,294
+20,970
| +23% | +$299K | ﹤0.01% | 960 |
|
|
2021
Q4 | $1.95M | Buy |
92,324
+72,924
| +376% | +$1.54M | ﹤0.01% | 968 |
|
|
2021
Q3 | $509K | Hold |
19,400
| – | – | ﹤0.01% | 1619 |
|
|
2021
Q2 | $605K | Hold |
19,400
| – | – | ﹤0.01% | 1561 |
|
|
2021
Q1 | $595K | Hold |
19,400
| – | – | ﹤0.01% | 1572 |
|
|
2020
Q4 | $666K | Hold |
19,400
| – | – | ﹤0.01% | 1537 |
|
|
2020
Q3 | $597K | Buy |
19,400
+17,400
| +870% | +$535K | ﹤0.01% | 1484 |
|
|
2020
Q2 | $62K | Buy |
+2,000
| New | +$62K | ﹤0.01% | 1655 |
|